Diagnosed with metastatic prostate cancer in summer of 2022, including soft tissue, even though PSA only 9. Did triple therapy and brain SRT with the Duke Cancer Center in 2022.
Biopsied and tested - only mutation is CDC73, which doesn’t seem to mean much in prostate cancer. High NY-ESO-1, which also doesn’t seem to be very actionable at this time.
Have remained on Lupron and Zytiga. Have had stable scans since end of chemo, with a PSA at .01 or below (though there is some question about how reliable PSA is in my case). MO said about 1% of metastatic cancer patient's PSA is not a good indicator of their cancer status.
CEA began rising in summer of 2024. In October, with CEA in 60’s, MO suggested we begin Pluvicto. PSMA scans are highly concordant with FDG scans.
Have had two treatments since then. Scans show slight decrease in some lung spots, but not in other lung spots, and no change in bones. CEA continues to rise (128 yesterday).
Has anyone else had a tepid response to Pluvicto with first couple of treatments, but then it improved? Has anyone had a CEA that continued to rise while on Pluvicto? Thoughts? I see my MO next week. He has indicated he would like to continue with Pluvicto. I’m wondering if it’s non-PSMA avid growth that is causing the rising CEA and it’s just not showing on the current scans.